Control of myopia progression by low-dose atropine (0.01%, 0.025% and 0.05%), defocus incorporated multiple segments/highly aspherical lenslets spectacles, and combined therapy in European children: A 3-year retrospective study
Optom Vis Sci . 2026 Mar;103(3):e70007. doi: 10.1002/ovs2.70007. ABSTRACT PURPOSE: Myopia control is crucial for pediatric eye care professionals. Although various treatments exist, their comparative efficacy, particula…